This clinical trial tests how well a culturally and linguistically tailored program works to improve colorectal cancer (CRC) screening in Chinese Americans. Chinese immigrants suffer from a high burden of CRC mortality. Many CRC deaths can be prevented by early detection; 5-year survival rates exceed 90% for CRC diagnosed at an early stage compared to only 14% for advanced disease. However, only 40% of CRC cases in Chinese Americans are diagnosed early. Screening with stool-based testing (e.g., fecal immunochemical testing, deoxyribonucleic acid
-FIT, guaiac fecal occult blood test) or direct visualization (e.g., colonoscopy, computed tomography colonography, sigmoidoscopy) can substantially decrease CRC deaths. A culturally and linguistically tailored intervention delivered by trained community health workers may increase participants’ understanding of CRC screening, address screening-related barriers, and enhance motivation to complete screening.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07361614.
Locations matching your search criteria
United States
New York
New York
Laura and Isaac Perlmutter Cancer Center at NYU LangoneStatus: Active
Contact: Suzanne Vang
Phone: 646-501-3684
PRIMARY OBJECTIVE:
I. To assess the feasibility, acceptability, and preliminary efficacy of a culturally and linguistically targeted, CRC education program to improve CRC screening completion.
SECONDARY OBJECTIVE:
I. To understand potential mechanisms in the behavior change process relevant to CRC screening through an exploratory analysis of changes in CRC and CRC screening beliefs, knowledge, self-efficacy for CRC screening, barriers to care, and trust in health/community health workers; and participant engagement with intervention components.
OUTLINE:
Participants attend an educational session with a community health worker (CHW) that integrates narrative storytelling, visual aids, and interactive discussion to address CRC risk, screening modalities, and common misconceptions over 60-90 minutes on study.
After completion of study intervention, participants are followed up at 6 months.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationLaura and Isaac Perlmutter Cancer Center at NYU Langone
Principal InvestigatorSuzanne Vang
